Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Zonisamide, sold under the brand name Zonegran among others, is a medication used to treat the symptoms of epilepsy and Parkinson's disease. Chemically it is a sulfonamide. It is most commonly used as an anti-seizure medication in patients with focal or generalized epilepsy.
History, Applications, Research & Regions
Explore the main themes, entities and connections around Zonisamide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
also epilepsy treatment united used medication states zonegran japan symptoms patients focal effects parkinson's disease cyp3a4 obesity metabolism approved europe
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Zonisamide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Zonisamide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Zonisamide | ATC code | N03AX15 (WHO) | 1.00 | infobox |
| Zonisamide | Bioavailability | ~100% | 1.00 | infobox |
| Zonisamide | CAS Number | 68291-97-4 Y | 1.00 | infobox |
| Zonisamide | ChEBI | CHEBI:10127 Y | 1.00 | infobox |
| Zonisamide | ChEMBL | ChEMBL750 Y | 1.00 | infobox |
| Zonisamide | ChemSpider | 5532 Y | 1.00 | infobox |
| Zonisamide | CompTox Dashboard (EPA) | DTXSID9046023 | 1.00 | infobox |
| Zonisamide | DrugBank | DB00909 Y | 1.00 | infobox |
| Zonisamide | ECHA InfoCard | 100.118.526 | 1.00 | infobox |
| Zonisamide | Elimination half-life | 63 hours in plasma | 1.00 | infobox |
| Zonisamide | Excretion | Kidney (62%); Faeces (3%) | 1.00 | infobox |
| Zonisamide | Formula | C8H8N2O3S | 1.00 | infobox |
| Zonisamide | IUPHAR/BPS | 7047 | 1.00 | infobox |
| Zonisamide | KEGG | D00538 Y | 1.00 | infobox |
| Zonisamide | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Zonisamide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Zonisamide | Legal status | US: ℞-only | 1.00 | infobox |
| Zonisamide | Legal status | EU: Rx-only | 1.00 | infobox |
| Zonisamide | License data | US DailyMed: Zonisamide | 1.00 | infobox |
| Zonisamide | MedlinePlus | a603008 | 1.00 | infobox |
| Zonisamide | Melting point | 162 °C (324 °F) | 1.00 | infobox |
| Zonisamide | Metabolism | Liver through CYP3A4 | 1.00 | infobox |
| Zonisamide | Molar mass | 212.22 g·mol−1 | 1.00 | infobox |
| Zonisamide | PDB ligand | ZON (PDBe, RCSB PDB) | 1.00 | infobox |
| Zonisamide | Pregnancy category | AU: D | 1.00 | infobox |
| Zonisamide | Protein binding | 40% | 1.00 | infobox |
| Zonisamide | PubChem CID | 5734 | 1.00 | infobox |
| Zonisamide | Routes of administration | By mouth | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.